⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

ZTS

Zoetis Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

73.31USD

-0.2500 (-0.34%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
1)

Comparable Revenue

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY8.1B8.5B9.3B9.5B9.2B9.5B
Q12.0B2.0B2.2B2.2B2.3B—
Q22.1B2.2B2.4B2.5B2.5B—
Q32.0B2.2B2.4B2.4B2.3B—
Q42.0B*2.2B*2.3B*2.4B*2.2B—
2)

Comparable Earnings Per Share

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY4.495.075.476.026.216.53
Q11.261.191.311.341.42—
Q21.121.451.371.631.65—
Q31.131.291.501.631.51—
Q4.980*

Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.

1.14*
1.28*
1.36*
1.30
—